Lucy Bullock

Partner, London



Lucy Bullock is the Regional Section Head, EMEA M&A/Private Equity at White & Case based in London, specializing in advising sponsor-held portfolio companies from buy-out to exit.

Lucy advises portfolio companies in connection with their capital structures, consortia coinvestment terms, equity recapitalisations, management equity incentive schemes, international reorganisations, post-completion matters following a sponsor buyout, exit preparations and exits.

Lucy also regularly advises companies on their day-to-day general matters including governance and compliance matters and is often the "outsourced" general counsel for a number of companies.

Bars and Courts
England and Wales
Natural Sciences
Cambridge University


Representation of Ramudden Global, a Triton Partners portfolio company, on its acquisition of RSG International, a North American provider of infrastructure safety services.

Representation of Clinigen, a Triton Partners portfolio company, on its:

  • divestiture of its established brands portfolio to CNX Therapeutics;
  • sale of Proleukin to Iovance Biotherapeutics; and
  • sale of Lamda Laboratories to Adragos Pharma.

Representation of Triton Partners on its £1.3 billion recommended takeover offer for Clinigen Group plc through funds managed by Triton.

Representation of Avast plc, the FTSE100 global leader in digital security and privacy, on its proposed US$9.2 billion merger with NortonLifeLock Inc.

Representation of CVC Growth on its significant investment in Brightstarr Group (t/a Unily).

Representation of Alvogen in connection with the deSPAC of Alvotech with a Nasdaq-listed SPAC formed by Oaktree Capital Management for an enterprise value to Alvotech of $2.25 billion.

Represenation of Alvogen on the sale of its CEE business to Zentiva.

Representation of Alvogen on a wide range of advisory matters, including its capital structure, debt related matters and acquisitions, following an investment by among others CVC and Temasek.

Representation of Avast (prior to its IPO) on a wide range of advisory matters following an investment by CVC and Summit.

Representation of Avast on its IPO and admission to the Premium Listing Segment of the Official List and to trading on the Main Market of the London Stock Exchange.

Representation of Bluewater Energy and it various portfolio companies following acquisition and during investment periods.

Awards and Recognition

Named in MergerLinks' 2023 Rising Stars: Top UK PE Lawyers

Named in's Rising Stars: Europe's Best Up-and-Coming Private Equity Lawyers

Named as a 2021 finalist at the Women in Business Law awards; "Private Equity lawyer of the year" category